03.11.2014 12:25:42
|
Covance Q3 Profit Increases - Quick Facts
(RTTNews) - Covance Inc. (CVD) reported that its third-quarter net income increased to $66.00 million from $44.20 million in the prior year quarter. Earnings per share were $1.16 up from $0.78 last year.
Pro forma earnings per share were $0.98, up 18.2% over the third quarter of 2013. Analysts polled by Thomson Reuters expected the company to report earnings of $0.98 per share for the quarter. Analysts' estimates typically exclude special items.
Net revenues for the quarter grew to $627.08 million from $606.72 million in the previous year. Wall Street expected revenues of $650.98 million for the quarter.
The company expects fourth quarter revenue to be in the range of $625 million to $635 million and earnings per share to be in the range of $0.95 to $0.98. Analysts expect the company to report earnings of $1.02 per share and revenues of $662.98 million for the fourth-quarter.
The company projects 2014 earnings per share to be in the range of $3.78 to $3.81, excluding gains on sale, costs associated with its restructuring activities, and asset impairment charges. Analysts expect annual earnings of $3.86 per share. The company said in July that it expected adjusted earnings per share to be $3.78 to $3.92 for fiscal 2014.
Separately, Laboratory Corporation of America Holdings (LH) and Covance announced that they have entered into a definitive agreement under which LabCorp will acquire Covance for cash and LabCorp shares currently valued at $105.12 per Covance share, or an equity value of approximately $6.1 billion and an enterprise value of approximately $5.6 billion.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Laboratory Corp. of America Holdingsmehr Nachrichten
Keine Nachrichten verfügbar. |